TransMedics Group
TMDX
#4153
Rank
โ‚ฌ2.09 B
Marketcap
62,50ย โ‚ฌ
Share price
2.31%
Change (1 day)
-11.42%
Change (1 year)
Categories

P/E ratio for TransMedics Group (TMDX)

P/E ratio as of December 2024 (TTM): -115

According to TransMedics Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -115.272. At the end of 2022 the company had a P/E ratio of -49.4.

P/E ratio history for TransMedics Group from 2019 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-49.4314.9%
2021-11.9-28.24%
2020-16.663.85%
2019-10.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-35.1-69.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-0.8095-99.30%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.